I don't think it has anything to do with age. Lifeloc is attending some of these conferences/trade shows, and making progress in their development of the "marijuana breathalyzer." The CEO has demonstrated a very strategic effort, and has financed the entire R&D by utilizing existing cash flow, without borrowing or diluting the stock - which investors should applaud. They are very experienced in this field, and know the paths to regulatory approval vs. some of their competitors.

You can't make a press release without "material information." If you do, and continue to pump your stock without any substantial basis, you just set the company up for class action lawsuits by disgruntled shareholders when the stock gets pummeled. Companies use "Safe Harbor" statements in their releases, but they are not foolproof. Lifeloc has been very conservative in releasing any press releases, that's why I feel when they do have some positive material information to release, shareholders should be pleasantly rewarded.

Cannabix has had no income, and continues to dilute shareholder equity. Their stock has more than doubled in just a few short days - all on a stationary alcohol breathalyzer for offenders, much like Lifeloc's Sentinel, which has been in use for years... Lifeloc's RADAR device is lightyears ahead of Cannabix's new device, they just need to work out the biometrics in the RADAR system, and it will come to fruit.

I can feel the momentum building, and my opinion is that Lifeloc will come out on top, as will it's investors - which have been very, very patient.

BLOZF is working on close to a triple because of a presentation they are making this Friday at the IACT on the topic of cannabis breast testing.

Would it have killed Lifeloc to present their current findings on the topic. Where is the drive, where is the passion, where is the work ethic?

Even so, why can’t we find someone who is part of the Lifeloc team who actually cares about being a public company and is concerned about shareholder value. Wouldn’t you think that for those who own shares, they would want them to increase in value. Why is it this difficult for them to act like a public company and participate in presentations, bring public awareness, post on social media, share progress, etc.

I’m telling you, if Lifeloc were run by the same team at Cannabix, this would be a totally different story.

I just want to see some changes being made. Someone who actually cares needs to join the team.

I think part of Lifeloc's problem is that 3/5 of the Board is 82 years old and up. The 'youngsters' are Vern's son and the CEO. Not exactly confidence inspiring...

This is something Lifeloc really should have been involved in:

https://www.iactonline.org/resources/Documents/IACT%202024/W5%20-%20Cannabis%20Breath%20Testing%20-%20Technology%20and%20Analytical%20Considerations.pdf

Cannabix and Hound Labs are making presentations on Cannabis breath testing this Friday. You can see how Cannabix stock price jumped on this news.

When are we going to get Lifeloc to step up to the plate and at least start swinging? You would think after almost 10 years they would be able to present something.

Lifeloc is an exhibitor at this years annual IACT (International Association for Chemical Testing) conference that is happening this week:

https://www.iactonline.org/page-1709724

Perhaps that is what brought us some volume on Friday?

The fingerprint tests are pass/fail, whereas Lifeloc's product gives a quantitative measurement - meaning Lifeloc's product is superior in proving a subject was over a specified limit. DADDS https://dadss.org/ is developing two products for alcohol tests in automobiles, and is probably the farthest along in that area - again, not for police/court use, only to act as an interlock device - which Lifeloc sells a good deal of their products to other interlock companies. Fuel cell technology remains the far superior method of testing, and Lifeloc actually manufactures it's own fuel cells for use in it's testing devices, as well as purchases some from other manufacturers.

Codeine is an opioid, and substance of abuse, but it sits low on the list compared to fentanyl, heroin, cocaine, Meth, Marijuana, etc.

Lifeloc gave a good synopsis of their competitors in their latest filing...

Competition and Markets
We sell our products in a highly competitive market and we compete for business with both foreign and domestic manufacturers. Most of our competitors are
larger and have substantially greater resources than we do. In addition, there is an ongoing risk that other domestic or foreign companies who do not currently
service or manufacture products for our target markets may seek to produce products or services that compete directly with ours.
We believe that considerations regarding competition for sales of alcohol monitoring products and services include regulatory approvals, product performance,
product delivery, quality, service, training, price, device reliability, ease of use and speed. We sell certain of our components to customers for incorporation
into their own product lines and for resale under their own name. We believe that, while our resources are more limited than those of our competitors, we will
continue to compete successfully on the basis of product innovation, quality, reputation and continued customer service excellence.

One of our leading competitors is Intoximeters, Inc. of St. Louis, Missouri, a long-established company with strong name recognition in the field of alcohol
testing. It has well-established sales channels, a large customer base, and a broad product line. CMI, Inc. of Owensboro, Kentucky, another major competitor,
also has a well-established name, a strong position in stationary units used in police work, and international market coverage. Drägerwerk AG & Co. KGaA,
based in Germany, manufactures safety and gas testing equipment. Its breath alcohol testers are respected for their quality and performance.
Our competition in the development of a marijuana breathalyzer includes Cannabix Technologies, Inc., a developer of marijuana and alcohol breathalyzer
technologies for law enforcement, workplaces and laboratories that is working on developing delta-9 THC and alcohol screening devices, and Hound Labs,
which is also developing a marijuana breathalyzer. Both competitors in this space have raised significant funds to develop their testing technology.
In addition, other technologies for the measurement of breath alcohol exist and are employed in other market and application segments where the technology
may be more suitable or developed to specific requirements. These include:
• Infrared devices, which use infrared light absorption to detect breath alcohol. These devices generally lack portability, and are usually found in fixed
locations, such as police stations, where subjects are brought for testing. This technology has the advantage of being mandated by law in most states for
evidential use in breath testing.
• Semiconductor breath testing technology, which is used primarily in consumer breathalyzers. Its primary advantage is low cost, but the technology is
not widely accepted by professional users as being as accurate as fuel cell technology.
• Chemical tests, which are based on urine and saliva testing. This approach to alcohol testing is more invasive, less convenient than breath testing, and
may require subsequent analysis for results.
• Blood alcohol tests, which require blood samples. These tests are widely believed to be the most accurate form of alcohol testing because they measure
blood alcohol content directly from a sample of the subject's blood. However, the results are not instantaneous, and the tests are more invasive and
expensive than breath alcohol testing

INBS has a fingerprint test that gives results in 10 minutes and they're going for FDA approval. The FDA approval will be for codeine first. Just is a yes/no test, not down to any measurements. Do you see this as competition for Lifeloc?

“Want to smoke weed at home? Smoke weed at home. If it’s legal, fine,” said ATA President Chris Spear. “Do not get behind the wheel of an 80,000-pound vehicle. We need to have strong standards, and we need to enforce the law.”

https://www.marijuanamoment.net/record-number-of-truck-drivers-refuse-to-take-drug-tests-as-more-states-legalize-marijuana/?

They still plan on introducing the product this year, and have identified the end users for Beta Testing, and have them in place - which is good. The fact that they improved accuracy by 50% is a great advancement. I believe they are still on the same timeline/track, but are simply giving themselves some breathing room for what the CEO calls their "Final Push" to commercialization, or a way of "sandbagging." Introducing the product this year is enough for me, and I would expect a great market response to it, in terms of share price. Commercialization would be the next milestone, and if/when it occurs, again - an overwhelming market response would be expected in my opinion.

I took my time, and read through both the 8k, and 10k. A lot of my questions I presented on a post last week, were answered in the reports. They discussed their competitors - including cannabix, Hound Labs, and Drager, as well as the huge amount of money that their competition had to raise to fund their research, whereas Lifeloc has funded all of their research organically. They explained that the constraints that they are experiencing with the RADAR device is in the Biometric Identification, and a third party is actively working to resolve those issues. Their revenue has increased, and they expect it to increase in the future, with enough funds in place to fund operations for another year.

Am I thrilled with the report, not overly, but as a long term investor, I feel very satisfied with the continued direction of the company and management. With the recent interest in cannabis stocks - gaining momentum due to the world's acceptance of marijuana, and legalization trends, I am confident Lifeloc will hold it's ground in relation to it's share price.

I wonder why they decided not to go with the standard "by the end of the year" statement and they pushed commercialization out to next year. I really was expecting more from this report. We are working on 4 years of the same old same old.

Annual Revenues of $9,329,566 is just a hair off of all time record revenues for Lifeloc:

2010 - $6,118,960
2011 - $8,290,852
2012 - $6,838,551
2013 – $8,425,667
2014 - $9,341,984
2015 - $8,826,473
2016 - $8,381,135
2017 - $7,990,738
2018 - $8,437,654
2019 - $8,751,823
2020 - $6,356,702
2021 - $7,054,430
2022 - $8,481,992
2023 - $9,329,566

Looks like commercialization is pushed out to 2025, but they got detection down to 5 ng from 10 ng. As usual good and bad.

Crickets....

Well done! You can have my vote for new CEO.

Still no report. They have never gone into the month of April and released their earnings report so this is a first.

Hopefully they have something new and exciting to share and they are taking their time getting it together.

Increased revenues would be nice, but unfortunately, revenues drive stocks in the S&P, not so much in the OTC. At some point, management is going to have to put a little emphasis on their achievements. They have been dragging the Spin DX along far too long, with talks of commercialization last year, then this year, with no report of substantial advancement. Simply releasing an 8K is not going to do it...

I would like to hear of positive results from Beta testing - improved accuracy, portability (incorporation into the LX9 platform, or at east a timeline), and most importantly - preparation to put this device into the hands of real world users, police, etc. Show us the end product. If commercialization is expected this year, which there is only 8 months remaining, I would expect to hear that the product is nearing production - preparing to increase manufacturing personnel, inventory, etc. Ramp up marketing, social media, news media sources, collaborate with Mother's Against Drunk Driving.

Many questions...

With legalization in Germany, where do their distributors stand in preparedness, and what is the impact on their competitors in Germany, mainly Draeger. What products does Draeger have that would actively compete with the SpinDx technology? Will the saliva testing be an acceptable form of testing in Germany? What is the $$$ market for this device in Germany? Are there any collaborative efforts in the works, which could aid in capturing market share in Germany?

With the current trend in America going full out cannabis, with rescheduling a good possibility this year, what is the forecast for the $$$ the SpinDx could capture in the US? Who are the main competitors in the the US? How do products from companies like Cannabix and Hound Labs compare with Lifeloc's, and what market share is Lifeloc capable of achieving? In reference to newer alcohol screening devices such as infrared scanning, finger touch sensing - what impact does Lifeloc see in the newer technology making Fuel cell membrane technology obsolete? How will the new requirement for US automakers to include alcohol sensing equipment in new builds affect Lifeloc? Is Lifeloc able to capture any of that market? What is Lifeloc's position of the new DADSS research in alcohol sensing technology, and how do they see their sales being impacted, once this new technology is implemented?

RADAR Device? Where does the technology stand now, since they put it on the back burner. Do they see implementing this device into a multifunctional, drugs of abuse device? When will sales begin on the basic alcohol device? What is the market for the RADAR device in $$$?

Most importantly ,they need to release their accomplishments in a manner that exploits their accomplishments, without falsely pumping the stock. Simply releasing a quarterly report, which gains the interest of no one, is not going to move the stock much. Let investors, and traders alike know that there is a company called Lifeloc Technologies, and they are setting the trend in THC testing, along with other drugs of abuse. There is no better time than now.

If they supply us with something of substance in this upcoming report, maybe we should take it upon ourselves to disseminate all pertinent info to some of the social media outlets and see if we can build some interest.

Are you looking for anything in particular from this upcoming report?

I’m looking to see record revenues of over $10 million for the year and something substantial that we can work off of for progress being made on the SpinDx device. I would really love to see something more than just another “by the end of the year” statement from them.

Thin is an understatement. The majority of the outstanding shares are held by insiders - and they have been slowly starting to buy more on the open market. It's traded about 300 shares in the past two weeks, and has a Market Cap around 8 Million. There is definitely not many shares available to freely trade.

If you compare that to Cannabix, which Market Cap is over 3x that of LCTC, or Hound Labs, which is privately held, and probably valued somewhere around 150 Million, or almost 20x LCTC Market Cap, you can see how grossly undervalued Lifeloc currently trades. This could easily trade at $30, and still be reasonable priced in my opinion. And, if momentum players where to be drawn in, the sky is the limit as to how quickly, and high this could possibly trade. Of course, I don't have to say this, because most people on this board who read these comments, already know this. Trick is, increasing awareness, and that ultimately lies in the hands of Lifeloc's management team.

Getting some volume in this thing is the key. We have been stuck in this $2 consolidation range between $1.50 and $3.50 for a year and half now. Just a bit of volume and a move over $4.00/share would be a nice start. Many of the other stocks in the marijuana sector have seen moves of 50%-300% over the last 2 weeks. We could use some of that carry over to help us get above this $4.00 resistance level. It seems as thin as it's ever been so just a bit of volume in either direction could easily move this.

I was thinking the same thing - I was surprised that they didn't report earnings last Friday after the bell. Volume has completely dried up, and I have a feeling we are about to get a big move to the upside, or a big move to the downside soon. Timing is right for everything to work in Lifeloc's favor, the ball is in their court. Hopefully shareholder's patience will pay off - Time will tell...

I was thinking the same thing - I was surprised that they didn't report earnings last Friday after the bell. Volume has completely dried up, and I have a feeling we are about to get a big move to the upside, or a big move to the downside soon. Timing is right for everything to work in Lifeloc's favor, the ball is in their court. Hopefully shareholder's patience will pay off - Time will tell...

Why do I get the feeling that we will get earnings after the close today with the market closed tomorrow and a long weekend? That seems like typical Lifeloc. There has been only 1 instance where Lifeloc reported after March 28th and that was in 2020 when they reported on March 31st. Wonder why this earnings report has been pushed this far into the month of March.

I have to imagine earnings are due out any day now.

All interest in this company has been lost. It has been over 5 months since we have heard anything from them. This is why they don’t participate in any of the sector momentum.

I just want something to change. Give us some hope here. Let us hear something that gets more people interested.

I don’t even think a record earnings report is going to move this. We need more. We deserve more.

Well at least they didn't post earnings after the bell on a Friday... Good news is Canopy Growth (CGC), almost tripled their share price this week.

Looks like cannabis stocks are on fire this morning. Time for some good news Lifeloc... The "New America" needs you now, more than ever!

We should see Lifeloc report first quarter and 2023 annual earnings this week. We are looking for annual net revenue to come in higher than last year's $8.5 million. There is a chance they report the highest annual revenue ever as a public company.

Here's what we heard this time last year:

We believe our most important goal and best opportunity remains the convergence of the global need for rapid detection of drugs of abuse with Lifeloc's proven capability to build easy-to-use portable testing equipment. We are focusing our research and development efforts on leveraging the SpinDx™technology platform, sometimes referred to as "Lab on a Disk," to develop a series of devices and tests that can be used at roadside and in emergency rooms, forensic labs and workplace testing to get a rapid and quantitative measure for a panel of drugs of abuse, beginning with a device that allows for detection of delta-9-THC (the major intoxicating component of the cannabis plant) from a test subject's saliva. Testing has commenced to validate the SpinDx technology against the definitive standard liquid chromatography-mass spectroscopy (LCMS) measurement utilizing human samples.The LCMS data are validating the SpinDx test results on real-world human saliva tests at a limit of detection of approximately 10 ng/ml. Work continues to improve the robustness and convenience of operation. Following the release of the SpinDx saliva testing system, which is expected this year and is projected to result in commercialization in 2024, development will accelerate on combining our LX9 breathalyzer with the THC SpinDx detection unit with their coupling to be our marijuana breathalyzer system.

We need to see some progress being made with this report.

I think it's fair to assume the THC part of the Spin DX platform is near completion. We have been here before with hiring, along with their talk of commercialization by the end of the year. There is a large platform of drugs they intend to add to their discs of consumable products, which may need further R&D - Cocaine, fentanyl, etc. Hopefully this is where the focus on further validation is required. Time will tell.

Would it be fair to assume that the SpinDx device is completed if they are hiring for a research technician to "validate tests for this exciting new technology in preparation for commercial launch."

Or am I just wishful thinking?

One step closer:

https://www.indeed.com/viewjob?jk=6096bba57bffb1a3

`Lifeloc Technologies, a leader in commercial and professional breathalyzer testing technology, is looking to hire a Research Technician to support research, development, and commercialization of its latest product for detection of controlled substances. This position will support research to develop and validate tests for this exciting new technology in preparation for commercial launch.

Specifically, the Laboratory Technician will be expected to aid in the development and testing of antibody-based reagents and equipment, establish tests with the project manager for validation of the device, and then assist company personnel with scale-up processes for manufacturing and reagent packaging for final commercialization.

I am on board with the idea of an annual shareholders meeting conference call livestream where they also demonstrate the SpixDx technology but I wouldn't hold my breath on that one. These guys don't seem to want to go out of their way for anything.

I get frustrated because on a daily basis we see the stock market hitting new highs and Lifeloc just continues to trade near lows. Any investment over the last couple years would have done better than this one. I don't want to sit here and read another earnings report that tells us "ready by the end of this year". I want to see someone who can get in there who has the determination and drive to finish this thing up.

I would possibly consider it. I have enough invested to justify a visit, but believe we could probably achieve just as much by reading their quarterly/year end reports, as well as any proxy votes we receive. They most likely will not disclose anything more in person, other than what they report in their filings. I want to see what comes about over the next month or two first. I think the most that would be gained is putting a face to the name of the board members, as well as show that the people that have been investing in their company, are real people, and that they care enough about their investment, and Lifeloc Technologies, to travel across the country for their annual meeting. A better idea would be to request that the meeting be live streamed, with a question and answer session at the end of the meeting for investors, and possibly demonstrate the current Spin DX model. This is the norm, and would not require much from the company, other than a video cam, microphone, and whichever technology they decide to stream the meeting, such as Zoom.

I don't think you will be impressed by their manufacturing facility, not because anything is wrong with it, but for the main reason that most manufacturing facilities are lack-luster. I have worked in many Fortune 500 company electro-mechanical manufacturing facilities - and none were very impressive to me. I do believe that they have expanded, or are about to expand their manufacturing facility, by not renewing some of the space that they lease out in the building that they own. They have done this in preparation, and anticipation for ramping up production.

I also doubt that they ever have much shareholder interest in their annual meetings.

I love the idea of attending the annual shareholders meeting. I wonder if they could give us a tour of the facility and show us where the magic happens with the SpinDx machine and truly find out how far along they are with this device. I want to see what management does on a daily basis and be able to experience first hand what happens in that facility.

I don't think they have ever had a shareholder show up to the annual meeting so I bet they would be shocked if a couple of us actually showed up.

Would anyone else from this message board be willing to make a trip to Wheat Ridge, Colorado this spring?

Maybe we should all attend the annual shareholders meeting this spring? We can all complain now, but you can also look at this as one of the greatest investment opportunities you may ever have. People in message board chat rooms always ask "How do you guys find, and invest in these stocks that move from $2.00 to $100 in a very short time, before they start their move...?" They feel they're late to the game, because they don't do their homework.

How can you not get excited about Lifeloc's last presentation at their Annual Shareholder's Meeting? Go through and read it page by page, it will only take a couple of minutes. https://lifeloc.com/pub/media/pdf/shareholderMeeting2023.pdf

If this was presented as a press release, on the wire, where traders and investors could actually be introduced to this company, I believe it would have attracted a larger interest in the stock. Lifeloc management decided to reserve doing this, and maybe for good reason. I still believe patience will pay off, and investors will be happily rewarded.

We have a lot to look for in the coming weeks, with earnings report just around the corner. Updates on the RADAR Device, and their outsourcing of the biometrics for the device, trade shows this spring, and most importantly - updates on the SpinDx Device, possibly Beta Testing News...? Who knows, but Lifeloc tends to think that this is going to be the year. If not this quarter, maybe next, but I believe we are getting very close to some ripe fruit.

The former CEO, Barry Knott at least put out PR’s and updated shareholders with news releases. He seemed to at least care about being a public company.

These guys show no interest in anything. There’s no interest from new shareholders here because there’s no interest from anyone from Lifeloc.

Unfortunately, they have no incentive to listen to anybody other than the Kornelsen's. ECIA is another majority Kornelsen held company with interesting technology which also never seems to make any progress. Would be great if the Kornelsen's would sell to someone who wants to see better results quicker.

We need to get people excited about what's to come from this company. Obviously we are getting no help from the owners and management of Lifeloc.

I have sent a couple emails to the CEO Dr. Wilkomm with no response.

No one wants to hear about another we will have our shit together "by the end of this year" statement.

We have a total of 6,500 shares traded since the beginning of this year. No one cares.

It has been 10 years since the state of Colorado had given Lifeloc a grant. "The grant, which requires matching funds from the company, will allow Lifeloc Technologies to speed development of a tool that will be marketed to law enforcement, corrections, schools and workplaces."

Can't we please just get someone with the right mindset and determination to come in here and figure this thing out.

Germany Legalizes Cannabis. Third EU Country to legalize Marijuana, and Lifeloc has distributors in all of them...

That could work, especially as you pointed out, if done after they put something positive out and the stock doesn't react because no one follows it. Bringing new sets of eyes on the stock could definitely help.

I battle with the idea of making a due diligence Wall Street bets Reddit post or something along those lines to get more people interested in this company. We should concentrate on that after we see something substantial that investors can get excited about to keep up the momentum.

We know that it only takes 1 right person with a float this small to get it moving.

Right now, Lifeloc is capturing less than 1% of the total $1.8 Billion breath analyzer market. I still think there’s a possibility of Lifeloc having a record earnings year and doing $10 million in revenue. But even that still leaves a ton of room for growth.

If we can start trading above the resistance at $4 and get something substantial to from Lifeloc to work off of, we could definitely be in a sweet spot over the near term.

This can easily surpass the $4.00 level with little volume. I held this stock back in 2016, and watched it go from about the same price it sits now, to over $23.00 in a few short days, with only a few thousand shares traded daily. We had record volume back in August of 2021, when there was talks of adding breathalyzers to automobiles manufactured in the US - which is still in the works by the way... The stock traded to $10 in a day or two - again, from around the same price it sits at today.

If there ever was a perfect storm in the stock market, this has the makings for it. What is needed, is a broader audience to trading this stock. I say it all of the time - we are the only people that follow this stock, along with the insiders. They don't do PR's or announce news on Market Watch or the Dow Jones News Wire, so the average investor/trader doesn't even know this company exists. If Lifeloc plays their cards right, they would begin to do some public press releases - which does not require you to search through and read an entire quarterly report. I understand why they probably refrained from this in the past, and the affinity of short sellers to fluffy press releases. But it's time Lifeloc brings the meat and potatoes to the table, and start firing out something substantial that investors can get excited about.

The market is growing in the breathalyzer field, and Lifeloc is poised to grab a piece of Billions of dollars...

https://finance.yahoo.com/news/breath-analyzer-market-revenue-worth-133800320.html

$4.00/share is a very key level for next week. Not much resistance above that. If we can get some volume, I think we have a shot at some new yearly highs. If we can couple that with some news, that would be perfect. It feels like it’s small cap season out there and I’d love for Lifeloc to participate.

You might be correct on that but it’s also going to depend on current demand and shares available for sale. Let’s just say Lifeloc was announced another grant by the state of Colorado to get them across the finish line, if supply (stock for sale) is limited I think we could get an explosive move upward and it wouldn’t take a lot. One high net worth individual could have this thing trading above $10 in a couple minutes.

I think Lifeloc would have to get on the NASDAQ for that kind of move, OTC stocks just don't move like that anymore since brokerages started restricting and/or charging for OTC trades.

HOLO is an example of a low float name that was less than $2.00 about a week ago. Today, it almost hit $100/share. According to Yahoo Finance, It's float is around 950,000 shares, is 70% owned by insiders and went from a market cap of about a $12 million to almost a $600,000,000 market cap in about a week. It's certainly possible.

On a daily basis, we see $1 and $2 stocks exploding and trading hundreds of percent higher. It feels like the time is right for low float small cap stocks with a catalyst or good news story to see a ton of upside potential. A $2.00 can go to $10 overnight. It's happening on a daily basis. It's go time Lifeloc. Let's see some magic.

I totally agree that timing is perfect and could not be any better. What I don't want to hear from them is another year of "commercialization by year's end" and no updates throughout the year. I still think they could have done a better job with this device. A working prototype was given to them 8 years ago! That's 2,920 days. Hounds Labs got a working device done in less time and are currently being rewarding for it with millions in revenue and a valuation close to half a billion dollars.

As far as an equity raise, I'm all for it. However, it would make more sense to me if they announced it when stock prices are higher. Big difference between issuing stock at a price of $2 vs. at a price of let's say $6. It would be worth their efforts to increase the stock price first whether through a series of PR's or just buying stock on the open market. They could move this stock higher with a couple thousand bucks and get rewarded with a couple extra million in financing when the time comes.

Love to see this thing bust its way through $4.00 resistance level and see what we can do.

With the current trend in testing, I think the timing is perfect for Lifeloc... They probably could have pushed a little faster by hiring more people, and working around the clock, that would require more money, and probable stock dilution by issuing more shares, or going into debt by borrowing money to finance the fast track. It's amazing that they have achieved getting this far by financing the rollout merely by day to day operations.

I would not be against Lifeloc issuing more shares as a form of equity funding, coupled with commercialization of their SpinDx platform, and funding it's rollout. Although it's commonly looked at as dilutive, and negative for stock price, I feel that this could be positive for the stock price, if done correctly. They could possibly gain some institutional ownership, add liquidity to the trading of the stock, and bring the freely tradeable shares into compliance of the required minimum public float of 1,000,000 shares for listing on the NASDAQ Exchange. I think that this is just a matter of time until something like this occurs.

The push towards oral drug testing is all well and good but where is the sense of urgency from Lifeloc?

They were given a prototype from Sandia National Laboratories almost 8 years ago:

https://www.sandia.gov/partnerships_reach/#!/stories?category=1&id=130&page=1

They didn't have to start this process from scratch. They were given a prototype that probably took years to develop. I feel like you and I could have developed this thing quicker than Lifeloc. I have to go back to the fact that when you are sitting on a potential multi-billion dollar opportunity like this, you do whatever it takes to make it happen. Work on weekends, spend the money on R & D, find the best minds in the workforce to get it done. I just don't see any of that with Lifeloc. Hopefully we see things change soon!

2023 was a historical year in drug testing... With the trend moving toward Oral fluid testing and breath testing...

https://ndasa.com/2024/01/21/staying-current-looking-back-at-an-historic-year-for-drug-testing/

Anyone have any idea where the volume came from today? I can account for 100 shares but that’s it.

It’s nice to see it break out of the $2 range it’s been in for over a year but can we sustain this or do we go right back down tomorrow? $4 is a huge resistance level to get through but hey - it has to start somewhere.

Let’s be thankful for this upward momentum.